摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-AMINO-1-[5-AMINO-1-(PHENYLMETHYL)-1H-IMIDAZOL-4-YL] ETHANONE | 69195-91-1

中文名称
——
中文别名
——
英文名称
2-AMINO-1-[5-AMINO-1-(PHENYLMETHYL)-1H-IMIDAZOL-4-YL] ETHANONE
英文别名
2-amino-1-[5-amino-1-(phenylmethyl)-1H-imidazol-4-yl]ethanone dihydrochloride;2-amino-1-(1-benzyl-5-amino-1H-imidazol-4-yl)ethanone dihydrochloride
2-AMINO-1-[5-AMINO-1-(PHENYLMETHYL)-1H-IMIDAZOL-4-YL] ETHANONE化学式
CAS
69195-91-1
化学式
C12H14N4O*2ClH
mdl
——
分子量
303.191
InChiKey
POCMDLAPECRQNR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.08
  • 重原子数:
    18.0
  • 可旋转键数:
    4.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    86.93
  • 氢给体数:
    2.0
  • 氢受体数:
    5.0

SDS

SDS:95725a484768636e01db6353b4342082
查看

反应信息

点击查看最新优质反应信息

文献信息

  • AMP Deaminase Inhibitors. 2. Initial Discovery of a Non-Nucleotide Transition-State Inhibitor Series
    作者:Brett C. Bookser、Srinivas Rao Kasibhatla、James R. Appleman、Mark D. Erion
    DOI:10.1021/jm990447m
    日期:2000.4.1
    described that inhibit adenosine 5'-monophosphate deaminase (AMPDA) or adenosine deaminase (ADA). The key steps involved in the preparation of these compounds are (1) treating the sodium salt of 6, 7-dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one (4) with an alkyl bromide or an alkyl mesylate to generate the N3-alkylated compound 5 and (2) reducing 5 with NaBH(4). Selective inhibition of AMPDA was realized when
    描述了一系列可抑制腺苷5'-单磷酸酶(AMPDA)或腺苷脱氨酶ADA)的N3取代的甲酰辅酶A糖苷配基类似物。制备这些化合物的关键步骤是(1)用烷基处理6,7-二氢咪唑并[4,5-d] [1,3] diazepin-8(3H)-one(4)的钠盐甲磺酸烷基酯生成N3-烷基化的化合物5和(2)用NaBH(4)还原5。当N 3-取代基包含羧酸部分时,实现了对AMPDA的选择性抑制。例如,具有己酸侧链的化合物7b抑制了具有K(i)=4.2μM的AMPDA和具有K(i)=280μM的ADA。大的亲脂性基团α取代为羧酸盐,提供了适度的效能提高,同时保持了选择性,如α-苄基类似物7j(AMPDA K(i)= 0.41 microM和ADA K(i)> 1000 microM)所示。这些化合物以及本系列论文中描述的其他化合物,是第一种适合测试AMPDA选择性抑制是否可以通过增加损伤部位的局部腺苷
  • 2-Amino-1-(5-amino-1H-imidazol-4-yl)ethanone and method of preparation
    申请人:Warner-Lambert Company
    公开号:US04117229A1
    公开(公告)日:1978-09-26
    2-Amino-1-(5-amino-1H-imidazol-4-yl)ethanone, 6,7-dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one and acid-addition salts thereof are disclosed. 2-Amino-1-(5-amino-1H-imidazol-4-yl)ethanone and its acid-addition salts are prepared by catalytically reducing an acid-addition salt of 2-amino-1-[5-amino-1-(protected)-1H-imidazol-4-yl]ethanone. 6,7-Dihydroimidazo[4,5-d][1,3]-diazepin-8(3H)-one and its acid-addition salts are prepared by reacting an acid-addition salt of 2-amino-1-(5-amino-1H-imidazol-4-yl)ethanone with a compound able to contribute a formyl group. The later product may subsequently be converted into (R)-3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[ 4,5-d][1,3]diazepin-8-ol. Furanose derivatives of 6,7-dihydroimidazo[4,5-d][1,3]diazepine are also disclosed and their methods of preparation. Lastly, a method for resolving an isomer mixture of 3-(2-deoxy-.beta.-D-erythro-pentafuranosyl)-3,6,7,8-tetrahydroimidazo[4 ,5-d][1,3]diazepin-8-ol compounds is related.
    本文披露了2-基-1-(5-基-1H-咪唑-4-基)乙酮,6,7-二氢咪唑[4,5-d][1,3]二氮杂环己酮及其酸盐衍生物。2-基-1-(5-基-1H-咪唑-4-基)乙酮及其酸盐是通过催化还原2-基-1-[5-基-1-(保护基)-1H-咪唑-4-基]乙酮的酸盐制备的。6,7-二氢咪唑[4,5-d][1,3]-二氮杂环己酮及其酸盐是通过将2-基-1-(5-基-1H-咪唑-4-基)乙酮的酸盐与能提供甲酰基的化合物反应制备的。后一产品随后可转化为(R)-3-(2-去氧-β-D-赤霉糖-3,6,7,8-四氢咪唑[4,5-d][1,3]二氮杂环己酮-8-醇。还披露了6,7-二氢咪唑[4,5-d][1,3]二氮杂环己烯呋喃糖衍生物及其制备方法。最后,还涉及一种解决3-(2-去氧-β-D-赤霉糖-3,6,7,8-四氢咪唑[4,5-d][1,3]二氮杂环己酮-8-醇化合物异构体混合物的方法。
  • Ring-expanded nucleosides and nucleotides
    申请人:Nabi
    公开号:EP1227103B1
    公开(公告)日:2006-07-26
  • Vicarious nucleophilic substitution of 1-benzyl-5-nitroimidazole, application to the synthesis of 6,7-dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one
    作者:Bang-Chi Chen、Sam T. Chao、Joseph E. Sundeen、John Tellew、Saleem Ahmad
    DOI:10.1016/s0040-4039(02)00053-9
    日期:2002.2
    Reaction of 1-benzyl-5-nitroimidazole with carbanion generated from chloroform and potassium tert-butoxide afforded 1-benzyl-4-dichloromethyl-5-nitroimidazole in 72% yield. This vicarious nucleophilic substitution reaction was successfully applied to the synthesis of 6,7-dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one, an important intermediate in the synthesis of natural and biologically active compounds. (C) 2002 Elsevier Science Ltd, All rights reserved.
查看更多